Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDDate | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
08/10/2023 | Q2 2023 | -$0.19 | -$0.24 | -0.05 | $0 | |
05/15/2023 | Q1 2023 | -$0.24 | $0 | |||
02/22/2023 | Q4 2022 | $0.36 | -$330.41 | -330.77 | $0 | |
11/14/2022 | Q3 2022 | -$0.40 | $0 | |||
08/18/2022 | Q2 2022 | -$224.74 | $0 | |||
05/20/2022 | Q1 2022 | -$0.29 | $0 | |||
04/07/2022 | Q4 2021 | -$0.26 | $0 | |||
12/08/2021 | Q3 2021 | -$0.23 | $0 | |||
08/16/2021 | Q2 2021 | -$40.60 | $0 | |||
06/04/2021 | Q1 2021 | -$0.94 | $0 | |||
09/29/2020 | Q3 2020 | -$0.00 | $0 |
Apexigen, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 14th, 2022 based off last year's report dates.
In the previous quarter, Apexigen, Inc. (:APGN) reported $0.24 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.19 by $0.43.
The conference call for Apexigen, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Apexigen, Inc.'s latest earnings report can be read online.
Apexigen, Inc. (:APGN) has a recorded net income of $0. Apexigen, Inc. has generated $-1.59 earnings per share over the last four quarters.
Apexigen, Inc. (:APGN) has a price-to-earnings ratio of -0.24 and price/earnings-to-growth ratio is -0.01.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED